The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane (DPPE) and tested their in vitro cytotoxicity in a human lung carcinoma cell line H460. One of the complexes $[Cu_2(DPPE)_3(CH_3CN)_2](ClO_4)_2 (C1)$, showed maximum cytotoxicity comparable to that of adriamycin. Treatment of cells with C1 caused DNA damage in vitro and activated the p53 pathway. Flow cytometry revealed that growth inhibition by C1 was due to a combination of cell cycle arrest and apoptosis. Simultaneous addition of C1 and adriamycin increased the cytotoxicity of either compound, suggesting the potential use of adriamycin in combination with C1. DNA binding and simulatio...
Recently, a novel phosphine copper(I) complex [Cu(thp)4][PF6] (CP), was identified as an efficient, ...
Schwarzbich S, Horstmann Nee Gruschka C, Simon J, et al. Stronger Cytotoxicity for Cancer Cells Than...
<div><p>Despite substantial research on cancer therapeutics, systemic toxicity and drug-resistance l...
The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of ...
Monocationic hydrophilic complexes [Cu(thp)4]+ 3 and [Cu(bhpe)2]+ 4 were synthesized by ligand excha...
Over the last few years a lot of research has been done to develop novel metal-based anti-cancer dru...
Monocationic hydrophilic complexes [Cu(thp)4](+) 3 and [Cu(bhpe)2](+) 4 were synthesized by ligand e...
The search for novel metal-based antitumor drugs other than Pt agents includes the investigation of ...
5-carbethoxy-2-thiouracil (eitotH2) reacts with CuX (X= Cl, Br, I) halides to give the formula [CuX(...
In the background that there is concerted effort to discover newer metal-based cancer chemotherapeut...
Among non-Pt compounds, copper complexes are considered good alternatives to platinum drugs as antit...
Three new complexes of Cu(I) have been synthesized using ancillary ligands like thiopyrimidine (tp) ...
The phosphane Cu(I) complex [Cu(thp)4][PF6], 1 (thp=tris(hydroxymethyl)phosphane) shows notable in v...
The search on copper coordination compounds as anticancer agents has boosted dramatically in the las...
Despite substantial research on cancer therapeutics, systemic toxicity and drug-resistance limits th...
Recently, a novel phosphine copper(I) complex [Cu(thp)4][PF6] (CP), was identified as an efficient, ...
Schwarzbich S, Horstmann Nee Gruschka C, Simon J, et al. Stronger Cytotoxicity for Cancer Cells Than...
<div><p>Despite substantial research on cancer therapeutics, systemic toxicity and drug-resistance l...
The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of ...
Monocationic hydrophilic complexes [Cu(thp)4]+ 3 and [Cu(bhpe)2]+ 4 were synthesized by ligand excha...
Over the last few years a lot of research has been done to develop novel metal-based anti-cancer dru...
Monocationic hydrophilic complexes [Cu(thp)4](+) 3 and [Cu(bhpe)2](+) 4 were synthesized by ligand e...
The search for novel metal-based antitumor drugs other than Pt agents includes the investigation of ...
5-carbethoxy-2-thiouracil (eitotH2) reacts with CuX (X= Cl, Br, I) halides to give the formula [CuX(...
In the background that there is concerted effort to discover newer metal-based cancer chemotherapeut...
Among non-Pt compounds, copper complexes are considered good alternatives to platinum drugs as antit...
Three new complexes of Cu(I) have been synthesized using ancillary ligands like thiopyrimidine (tp) ...
The phosphane Cu(I) complex [Cu(thp)4][PF6], 1 (thp=tris(hydroxymethyl)phosphane) shows notable in v...
The search on copper coordination compounds as anticancer agents has boosted dramatically in the las...
Despite substantial research on cancer therapeutics, systemic toxicity and drug-resistance limits th...
Recently, a novel phosphine copper(I) complex [Cu(thp)4][PF6] (CP), was identified as an efficient, ...
Schwarzbich S, Horstmann Nee Gruschka C, Simon J, et al. Stronger Cytotoxicity for Cancer Cells Than...
<div><p>Despite substantial research on cancer therapeutics, systemic toxicity and drug-resistance l...